Epstein Secrets

y appreciate your willingness to find a potential pathway to Bil= Gates and the Gates Foundation. By way of introduction, I have been a Professor at Weill-Cornell for th= last 30 years, and am best known for having invented the Ligase C=ain Reaction (LCR) and the Universal Array. I hold 46 issued US prtents, a

evices suitable f=r working in developing countries, and may be powered and run by a cell phone or smart device. • Current CDC approved EZ1-RT-P=R Taqman assay has LOD of 5,000 PFU/ml. This works when patient is&nbs=;febrile, i.e. has overt symptoms and may be contagious. • Next level of assay needs

appreciate your willingness to find a potential pathway to Bi=l Gates and the Gates Foundation. By way of introduction, I have been a Professor at Weill-Cornell for t=e last 30 years, and am best known for having invented the Ligas= Chain Reaction (LCR) and the Universal Array. I hold 46 issued=US patents, a

ricated devices that w=ll allow for electronic detection, obviating the need for expens=ve hardware used in most fluorescent detection schemes (i.e. Taqman a=says). As such, we are poised to combine these technologie= for rapidly identifying and providing quantitative viral load fo= all the VHF, Variol

lingness to find a potential pathway to Bil= Gates and the Gates EFTA_R1_01775910 EFTA02592815 By way of introduction, I have been a Professor at Weill-Cornell for th= last 30 years, and am best known for having invented the Ligase C=ain Reaction (ICR) and the Universal Array. I hold 46 issued US p=tents, a

devices suitable f=r working in developing countries, and may be powered and run by a cell phone or smart device. • Current CDC approved EZ1-RT-P=R Taqman assay has LOD of 5,000 PFU/ml. This works when patient is&nbs=;febrile, i.e. has overt symptoms and may be contagious. • Next level of assay needs